NB
NovaBridge Biosciences
NBP · NASDAQ
$1.61 -1.23% (-$0.02)
1M -14.81%
Market Cap $90.2M
P/E Ratio -
Div. Yield -
ROE 0.59%
Piotroski F-Score Weak
1/9Valuation
71 /100
Cheap P/B 2.73x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 94.82%
ROE 0.59%
ROA 53.39%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 8.09x
Int. coverage N/A
Stability
33 /100
Unstable Beta 1.50x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Srishti Gupta
Employees
30
Headquarters
Rockville
Nadcházející události
12 LIS
Earnings
Upcoming earnings report
31 BŘE
Earnings
Upcoming earnings report